What is she best known for?
The fields of study she is best known for:
Her scientific interests lie mostly in Immunology, Virology, Antibody, Vaccination and Immunogenicity.
In Immunology, she works on issues like Pneumococcal conjugate vaccine, which are connected to Serotype.
Her Virology research incorporates themes from Neisseria meningitidis, Papillomaviridae, Humoral immunity and Microbiology.
As part of her studies on Antibody, Kathrin U. Jansen often connects relevant subjects like HPV infection.
Her work investigates the relationship between Vaccination and topics such as Tolerability that intersect with problems in Reactogenicity.
Her Immunogenicity research is multidisciplinary, relying on both Adverse effect and Disease.
Her most cited work include:
- Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial (1372 citations)
- A controlled trial of a human papillomavirus type 16 vaccine. (1207 citations)
- Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults (653 citations)
What are the main themes of her work throughout her whole career to date?
Kathrin U. Jansen focuses on Virology, Immunology, Vaccination, Antibody and Microbiology.
The Virology study combines topics in areas such as Neisseria meningitidis, Molecular biology, Epitope and Bivalent.
Immunology is often connected to Pneumococcal conjugate vaccine in her work.
Her Vaccination study combines topics from a wide range of disciplines, such as Internal medicine, CD8 and Pediatrics.
Her Microbiology study incorporates themes from Mutant, Antigen and Staphylococcus aureus.
Her Immunogenicity research incorporates elements of Tolerability and Adverse effect.
She most often published in these fields:
- Virology (40.78%)
- Immunology (28.80%)
- Vaccination (22.33%)
What were the highlights of her more recent work (between 2018-2021)?
- Virology (40.78%)
- Vaccination (22.33%)
- Immunogenicity (18.12%)
In recent papers she was focusing on the following fields of study:
Virology, Vaccination, Immunogenicity, Antibody and Immune system are her primary areas of study.
Her study looks at the intersection of Virology and topics like Severe acute respiratory syndrome coronavirus 2 with 2019-20 coronavirus outbreak.
Her Vaccination research is under the purview of Immunology.
Her work is dedicated to discovering how Immunology, Pneumococcal conjugate vaccine are connected with Pneumococcal vaccine and other disciplines.
Her research in Immunogenicity intersects with topics in Safety tolerability, Tolerability and Internal medicine.
The study incorporates disciplines such as Neisseria meningitidis, Cancer, Infectious disease and Microbiology in addition to Immune system.
Between 2018 and 2021, her most popular works were:
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. (387 citations)
- Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. (341 citations)
- COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses. (246 citations)
In her most recent research, the most cited papers focused on:
Kathrin U. Jansen spends much of her time researching Vaccination, Immunogenicity, Antibody, Virology and Immunology.
Her Vaccination research focuses on CD8 and how it connects with T cell.
Kathrin U. Jansen usually deals with Immunogenicity and limits it to topics linked to Titer and Major histocompatibility complex and Epitope.
Her study of Immunization is a part of Antibody.
Her Virology research is multidisciplinary, incorporating perspectives in RNA, Meningitis and Severe acute respiratory syndrome coronavirus 2.
The concepts of her Immunology study are interwoven with issues in Tolerability, Pandemic and Pneumococcal conjugate vaccine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
